FDA Approved: CLONAZEPAM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for clonazepam submitted by Par Health USA, LLC, supporting continued use of this generic benzodiazepine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Panic Disorder

Drugs mentioned

• Clonazepam (Clonazepam)

Snippet

SUPPL AP for CLONAZEPAM (CLONAZEPAM)